Spontaneous tumor regression is a recognized phenomenon across various cancer types. Recent research emphasizes the alterations in autoantibodies against carbonic anhydrase I (CA I) (anti-CA I) levels as potential prognostic markers for various malignancies. Particularly, autoantibodies targeting CA I and II appear to induce cellular damage by inhibiting their respective protein's catalytic functions. Our study illuminates the profound impact of anti-CA I autoantibodies from patient serum on the esterase activity of human CA I, exhibiting inhibitory effects akin to the acetazolamide inhibitor. Concurrently, our newly synthesized mouse monoclonal IgG antibody, mAb 2B8, against human CA I showcased a potent inhibitory action. An in-depth exploration into mAb 2B8's binding dynamics with its target enzyme was undertaken. Leveraging epitope extraction and phage display library techniques, we identified the amino acid sequence DFWTYP (positions 191-196 of CA I) as crucial for mAb 2B8's interaction. In 3-D structural analysis, this sequence is spatially adjacent to a previously identified epitope (DFWTYP) that interacts with patient-derived autoantibodies. Critically, mAb 2B8 demonstrated an ability to infiltrate eukaryotic cells, engaging specifically with its intracytoplasmic target. This positions mAb 2B8 as a promising model for future studies aimed at tumor cell eradication.

Biomedical Research Center Slovak Academy of Sciences Bratislava Slovakia

Department of Biological and Biochemical Sciences Faculty of Chemical Technology University of Pardubice Pardubice Czech Republic

Department of Pharmaceutical Analysis and Nuclear Pharmacy Faculty of Pharmacy Comenius University Bratislava Slovakia

Institute of Chemistry Slovak Academy of Sciences Bratislava Slovakia

Institute of Microbiology Czech Academy of Sciences Prague Czech Republic

Institute of Normal and Pathological Physiology Centre of Experimental Medicine Slovak Academy of Sciences Bratislava Slovakia

Regional Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Brno Czech Republic

See more in PubMed

Imtaiyaz Hassan M., Shajee B., Waheed A., Ahmad F., Sly W. S. Structure, Function and Applications of Carbonic Anhydrase Isozymes. Bioorganic & Medicinal Chemistry . 2013;21(6):1570–1582. doi: 10.1016/j.bmc.2012.04.044. PubMed DOI

Lindskog S. Structure and Mechanism of Carbonic Anhydrase. Pharmacology & Therapeutics . 1997;74(1):1–20. doi: 10.1016/S0163-7258(96)00198-2. PubMed DOI

Sterling D., Reithmeier R. A., Casey J. R. Carbonic Anhydrase: In the Driver’s Seat for Bicarbonate Transport. JOP: Journal of the Pancreas . 2001;2(4 Suppl):165–70. PubMed

Villeval J. L., Testa U., Vinci G., et al. Carbonic Anhydrase I Is an Early Specific Marker of Normal Human Erythroid Differentiation. Blood . 1985;66(5) PubMed

Boone C. D., Pinard M., McKenna R., Silverman D. Catalytic Mechanism of α-Class Carbonic Anhydrases: CO2 Hydration and Proton Transfer. In: Frost S., McKenna R., editors. Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications . Springer, Dordrecht; 2014. DOI

Bartolomé M. J., de las Heras G., López-Hoyos M. Low-Avidity Antibodies to Carbonic Anhydrase-I and -II in Autoimmune Chronic Pancreatitise. The Scientific World JOURNAL . 2002;2:1560–1568. doi: 10.1100/tsw.2002.811. PubMed DOI PMC

Gambhir K. K., Ornasir J., Headings V., Bonar A. Decreased Total Carbonic Anhydrase Esterase Activity and Decreased Levels of Carbonic Anhydrase 1 Isozyme in Erythrocytes of Type II Diabetic Patients. Biochemical Genetics . 2007;45(5-6):431–439. doi: 10.1007/s10528-007-9086-x. PubMed DOI

Itoh Y., Reichlin M. Antibodies to Carbonic Anhydrase in Systemic Lupus Erythematosus and Other Rheumatic Diseases. Arthritis & Rheumatism . 1992;35(1):73–82. doi: 10.1002/art.1780350112. PubMed DOI

Karahan S. C., Guven S., Mentese A., Bacak A., Kopuz M., Ozeren M. Serum Anti-Carbonic Anhydrase I and II Antibodies and Idiopathic Recurrent Pregnancy Loss. Reproductive BioMedicine Online . 2009;19(6):859–863. doi: 10.1016/j.rbmo.2009.09.030. PubMed DOI

Kho K. H., Kim J. W., Kim S. C., et al. Identification and Intracellular Localization of Carbonic Anhydrase I in Gills, Heart, Muscle, and Intestine of Rainbow Trout, Oncorhynchus mykiss. Journal of the Korean Society for Applied Biological Chemistry . 2015;58(5):729–733. doi: 10.1007/s13765-015-0098-7. DOI

Mondrup M., Anker N. Carbonic Anhydrase Isoenzyme B in Erythrocytes of Subjects With Chronic Acidosis. Clinica Chimica Acta . 1979;92(3):361–366. doi: 10.1016/0009-8981(79)90214-6. PubMed DOI

Scher W., Parkes J., Friend C. Increased Carbonic Anhydrase Activity in Friend Erythroleukemia Cells During DMSO-Stimulated Erythroid Differentiation and Its Inhibition by BrdU. Cell Differentiation . 1977;6(5-6):285–296. doi: 10.1016/0045-6039(77)90003-3. PubMed DOI

Tange K., Yagi S., Takeshita E., et al. Oral Administration of Human Carbonic Anhydrase I Suppresses Colitis in a Murine Inflammatory Bowel Disease Model. Scientific Reports . 2022;12 doi: 10.1038/s41598-022-22455-y.17983 PubMed DOI PMC

Zheng Y., Wang L., Zhang W., Xu H., Chang X. Transgenic Mice Over-Expressing Carbonic Anhydrase I Showed Aggravated Joint Inflammation and Tissue Destruction. BMC Musculoskeletal Disorders . 2012;13 doi: 10.1186/1471-2474-13-256.256 PubMed DOI PMC

Tsou P., Katayama H., Ostrin E. J., Hanash S. M. The Emerging Role of B Cells in Tumor Immunity. Cancer Research . 2016;76(19):5597–5601. doi: 10.1158/0008-5472.CAN-16-0431. PubMed DOI

Bei R., Masuelli L., Palumbo C., Modesti M., Modesti A. A Common Repertoire of Autoantibodies Is Shared by Cancer and Autoimmune Disease Patients: Inflammation in Their Induction and Impact on Tumor Growth. Cancer Letters . 2009;281(1):8–23. doi: 10.1016/j.canlet.2008.11.009. PubMed DOI

Søgaard M., Farkas D. K., Ehrenstein V., Jørgensen J. O. L., Dekkers O. M., Sørensen H. T. Hypothyroidism and Hyperthyroidism and Breast Cancer Risk: A Nationwide Cohort Study. European Journal of Endocrinology . 2016;174(4):409–414. doi: 10.1530/EJE-15-0989. PubMed DOI

Takakura M., Yokomizo A., Tanaka Y., et al. Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer. ISRN Oncology . 2012;2012:1–10. doi: 10.5402/2012/768190. PubMed DOI PMC

Wang D.-B., Lu X.-K., Zhang X., Li Z.-G., Li C.-X. Carbonic Anhydrase 1 Is a Promising Biomarker for Early Detection of Non-Small Cell Lung Cancer. Tumor Biology . 2016;37(1):553–559. doi: 10.1007/s13277-015-3834-z. PubMed DOI

Kuo W. H., Chiang W. L., Yang S. F., et al. The Differential Expression of Cytosolic Carbonic Anhydrase in Human Hepatocellular Carcinoma. Life Sciences . 2003;73(17):2211–2223. doi: 10.1016/S0024-3205(03)00597-6. PubMed DOI

Mori M., Staniunas R. J., Barnard G. F., Jessup J. M., Steele G. D., Jr., Chen L. B. The Significance of Carbonic Anhydrase Expression in Human Colorectal Cancer. Gastroenterology . 1993;105(3):820–826. doi: 10.1016/0016-5085(93)90900-W. PubMed DOI

Frankel S. R., Walloch J., Hirata R. K., Bondurant M. C., Villanueva R., Weil S. C. Carbonic Anhydrase Is Aberrantly and Constitutively Expressed in Both Human and Murine Erythroleukemia Cells. Proceedings of the National Academy of Sciences . 1985;82(15):5175–5179. doi: 10.1073/pnas.82.15.5175. PubMed DOI PMC

Tanaka H., Tsukamoto T., Mizoshita T., et al. Expression of Small Intestinal and Colonic Phenotypes in Complete Intestinal Metaplasia of the Human Stomach. Virchows Archiv . 2005;447(5):806–815. doi: 10.1007/s00428-005-0040-1. PubMed DOI

Yoshihara T., Kadota Y., Yoshimura Y., et al. Proteomic Alteration in Gastic Adenocarcinomas From Japanese Patients. Molecular Cancer . 2006;5 doi: 10.1186/1476-4598-5-75.75 PubMed DOI PMC

Botrè F., Botrè C., Podestà E., Podda M., Invernizzi P. Effect of Anti-Carbonic Anhydrase Antibodies on Carbonic Anhydrases I and II. Clinical Chemistry . 2003;49(7):1221–1223. doi: 10.1373/49.7.1221. PubMed DOI

Mentese A., Fidan E., Alver A., et al. Detection of Autoantibodies Against Carbonic Anhydrase I and II in the Plasma of Patients With Gastric Cancer. Central European Journal of Immunology . 2017;42(1):73–77. doi: 10.5114/ceji.2017.67320. PubMed DOI PMC

Lakota J., Lanz A., Dubrovcakova M., Jankovicova B., Gonzalez A., Stern M. Antibodies Against Carbonic Anhydrase in Patients With Aplastic Anemia. Acta Haematologica . 2012;128(3):190–194. doi: 10.1159/000338826. PubMed DOI

Mentese A., Erkut N., Demir S., et al. Serum Carbonic Anhydrase I and II Autoantibodies in Patients With Chronic Lymphocytic Leukaemia. Central European Journal of Immunology . 2018;43(3):276–280. doi: 10.5114/ceji.2018.80046. PubMed DOI PMC

Lakota J., Skultety L., Dubrovcakova M., Altaner C. Presence of Serum Carbonic Anhydrase Autoantibodies in Patients Relapsed After Autologous Stem Cell Transplantation Indicates an Improved Prognosis. Neoplasma . 2008;55(6):488–92. PubMed

Minichová L., Škultéty Ľ., Lakota J. Autoimmune Phenomena and Spontaneous Tumour Regression. The Role of Carbonic Anhydrase I. Journal of Cellular and Molecular Medicine . 2021;25(11):5339–5340. doi: 10.1111/jcmm.16525. PubMed DOI PMC

Lakota J. Spontaneous Regression of Tumours. Possible Cross Reactivity of Autoantibodies against Carbonic Anhydrase I. Journal of Cellular and Molecular Medicine . 2023;27(22):3637–3640. doi: 10.1111/jcmm.17970. PubMed DOI PMC

Nissen C., Stern M. Acquired Immune Mediated Aplastic Anemia: Is It Antineoplastic? Autoimmunity Reviews . 2009;9(1):11–16. doi: 10.1016/j.autrev.2009.02.032. PubMed DOI

Skultety L., Jankovicova B., Svobodova Z., et al. Identification of Carbonic Anhydrase I Immunodominant Epitopes Recognized by Specific Autoantibodies Which Indicate an Improved Prognosis in Patients With Malignancy after Autologous Stem Cell Transplantation. Journal of Proteome Research . 2010;9(10):5171–5179. doi: 10.1021/pr1004778. PubMed DOI

Jankovicova B., Skultety L., Dubrovcakova M., Stern M., Bilkova Z., Lakota J. Overlap of Epitopes Recognized by Anti-Carbonic Anhydrase I IgG in Patients With Malignancy-Related Aplastic Anemia-Like Syndrome and in Patients With Aplastic Anemia. Immunology Letters . 2013;153(1-2):47–49. doi: 10.1016/j.imlet.2013.07.006. PubMed DOI

Colombo R., Pinelli A. Determination of the Dissociation Constant of Carbonic Anhydrase Inhibitors: A Computerized Kinetic Method Based on Esterase Activity Assay. Journal of Pharmacological Methods . 1981;6(3):177–191. doi: 10.1016/0160-5402(81)90107-8. PubMed DOI

Svobodova Z. Dot-ELISA Affinity Test: An Easy, Low-Cost Method to Estimate Binding Activity of Monoclonal Antibodies. Journal of Analytical & Bioanalytical Techniques . 2013;4(3) doi: 10.4172/2155-9872.1000168. DOI

Staros J. V. N-Hydroxysulfosuccinimide Active Esters: Bis(N-Hydroxysulfosuccinimide) Esters of Two Dicarboxylic Acids Are Hydrophilic, Membrane-Impermeant, Protein Cross-Linkers. Biochemistry . 1982;21(17):3950–3955. doi: 10.1021/bi00260a008. PubMed DOI

Jankovicova B., Rosnerova S., Slovakova M., et al. Epitope Mapping of Allergen Ovalbumin Using Biofunctionalized Magnetic Beads Packed in Microfluidic Channels. Journal of Chromatography A . 2008;1206(1):64–71. doi: 10.1016/j.chroma.2008.07.062. PubMed DOI

Plumb R. S., Johnson K. A., Rainville P., et al. UPLC/MSE; a New Approach for Generating Molecular Fragment Information for Biomarker Structure Elucidation. Rapid Communications in Mass Spectrometry . 2006;20(14):2234–2234. doi: 10.1002/rcm.2602. PubMed DOI

Supuran C. T., Scozzafava A., Casini A. Carbonic Anhydrase Inhibitors. Medicinal Research Reviews . 2003;23(2):146–189. doi: 10.1002/med.10025. PubMed DOI

Tsikas D. Acetazolamide and Human Carbonic Anhydrases: Retrospect, Review and Discussion of an Intimate Relationship. Journal of Enzyme Inhibition and Medicinal Chemistry . 2024;39(1) doi: 10.1080/14756366.2023.2291336.2291336 PubMed DOI PMC

Hnasko R. M., Stanker L. H. Hybridoma Technology. ELISA . 2015;1318:15–28. doi: 10.1007/978-1-4939-2742-5_2. PubMed DOI

Mitra S., Tomar P. C. Hybridoma Technology; Advancements, Clinical Significance, and Future Aspects. Journal of Genetic Engineering and Biotechnology . 2021;19(1) doi: 10.1186/s43141-021-00264-6.159 PubMed DOI PMC

Gondi G., Mysliwietz J., Hulikova A., et al. Antitumor Efficacy of a Monoclonal Antibody That Inhibits the Activity of Cancer-Associated Carbonic Anhydrase XII. Cancer Research . 2013;73(21):6494–6503. doi: 10.1158/0008-5472.CAN-13-1110. PubMed DOI

Stravinskiene D., Sliziene A., Baranauskiene L., Petrikaite V., Zvirbliene A. Inhibitory Monoclonal Antibodies and Their Recombinant Derivatives Targeting Surface-Exposed Carbonic Anhydrase XII on Cancer Cells. International Journal of Molecular Sciences . 2020;21(24) doi: 10.3390/ijms21249411.9411 PubMed DOI PMC

Supuran C. T., Scozzafava A. Carbonic Anhydrase Inhibitors and Their Therapeutic Potential. Expert Opinion on Therapeutic Patents . 2000;10(5):575–600. doi: 10.1517/13543776.10.5.575. DOI

Sun Z., Fu Y.-X., Peng H. Targeting Tumor Cells With Antibodies Enhances Anti-Tumor Immunity. Biophysics Reports . 2018;4(5):243–253. doi: 10.1007/s41048-018-0070-2. PubMed DOI PMC

Attarwala H. Role of Antibodies in Cancer Targeting. Journal of Natural Science, Biology and Medicine . 2010;1(1) doi: 10.4103/0976-9668.71675.53 PubMed DOI PMC

Neves H., Kwok H. F. Recent Advances in the Field of Anti-Cancer Immunotherapy. BBA Clinical . 2015;3:280–288. doi: 10.1016/j.bbacli.2015.04.001. PubMed DOI PMC

Mazor R. D., Nathan N., Gilboa A., et al. Tumor-Reactive Antibodies Evolve From Non-Binding and Autoreactive Precursors. Cell . 2022;185(7):1208–1222.e21. doi: 10.1016/j.cell.2022.02.012. PubMed DOI

Lakota J., Vulic R., Dubrovcakova M., Tyciakova S. Sera of Patients With Spontaneous Tumour Regression and Elevated Anti-CA I Autoantibodies Change the Gene Expression of ECM Proteins. Journal of Cellular and Molecular Medicine . 2017;21(3):543–551. doi: 10.1111/jcmm.13000. PubMed DOI PMC

Vulic R., Tyciakova S., Dubrovcakova M., Skultety L., Lakota J. Silencing of CA1 mRNA in Tumour Cells Does not Change the Gene Expression of the Extracellular Matrix Proteins. Journal of Cellular and Molecular Medicine . 2018;22(1):695–699. doi: 10.1111/jcmm.13315. PubMed DOI PMC

Adamus G., Karren L. Autoimmunity Against Carbonic Anhydrase II Affects Retinal Cell Functions in Autoimmune Retinopathy. Journal of Autoimmunity . 2009;32(2):133–139. doi: 10.1016/j.jaut.2009.02.001. PubMed DOI PMC

Salman T. Spontaneous Tumor Regression. Journal of Oncological Science . 2016;2(1):1–4. doi: 10.1016/j.jons.2016.04.008. DOI

Papac R. J. Spontaneous Regression of Cancer: Possible Mechanisms. In Vivo . 1998;12(6):571–578. Vivo. PubMed

Jessy T. Immunity over Inability: The Spontaneous Regression of Cancer. Journal of Natural Science, Biology and Medicine . 2011;2(1):p. 43. doi: 10.4103/0976-9668.82318. PubMed DOI PMC

Challis G. B., Stam H. J. The Spontaneous Regression of Cancer: A review of cases from 1900 to 1987. Acta Oncologica . 1990;29(5):545–550. doi: 10.3109/02841869009090048. PubMed DOI

Udupa K., Philip A., Rajendranath R., Sagar T., Majhi U. Spontaneous Regression of Primary Progressive Hodgkin’s Lymphoma in a Pediatric Patient: A Case Report and Review of Literature. Hematology/Oncology and Stem Cell Therapy . 2013;6(3-4):112–116. doi: 10.1016/j.hemonc.2013.06.004. PubMed DOI